legistlation

MCIT breakthrough device payment pathway included in Cures 2.0 bill
Medtech Dive
Thu, 11/18/21 - 10:42 am
devices
Medtech
legistlation
Cures 2.0
breakthrough device
MCIT
Medicare
BioBonds Would Use Wall St. Tools to Fund Medical Research
NY Times, NY
Mon, 07/12/21 - 11:45 pm
funding
R&D
BioBonds
legistlation
Lawmakers urge White House to abolish X-waiver for buprenorphine prescription
Beckers Hospital Review
Wed, 02/10/21 - 10:15 am
congress
Joe Biden
legistlation
buprenorphine
X-waiver
FiercePharmaPolitics—States still exploring drug pricing despite congressional gridlock
Fierce Pharma
Mon, 07/20/20 - 11:11 am
drug pricing
politics
regulatory
legistlation
FiercePharmaPolitics—Grassley's bipartisan drug pricing push in limbo as lawmakers stop negotiating
Fierce Pharma
Mon, 07/6/20 - 11:04 am
drug pricing
legistlation
regulatory
Charles Grassley
The Pelosi Plan and “Me Too” Drugs
BIOTechNow
Tue, 11/5/19 - 10:27 am
regulatory
legistlation
me-too drugs
Nancy Pelosi
Researchers Estimate Costs of Exclusivity Extensions to Encourage Antibiotic Development
RAPS.org
Mon, 10/21/19 - 06:04 pm
legistlation
regulatory
exclusivity
antibiotics
Pelosi drug plan would save $370B, but could reduce R&D, forecasters say
Biopharma Dive
Mon, 10/14/19 - 11:56 pm
legistlation
Nancy Pelosi
Medicare
CBO
drug pricing
Precision Medicine Gets A Boost From Congress
Forbes
Thu, 10/10/19 - 09:48 am
precision medicine
Advancing Access to Precision Medicine Act
legistlation
pediatric rare diseases
Sticker prices in drug ads just got closer with bipartisan backing in Senate
Fierce Pharma
Wed, 08/1/18 - 11:54 am
legistlation
drug pricing
Transparency Is All The Rage In State Legislatures
CP Wire
Tue, 04/17/18 - 09:46 am
legistlation
transparency
drug pricing